PANTOPRAZOLE SODIUM
Manufacturer: REMEDYREPACK INC.
Score: 141.0
Pantoprazole sodium is a proton pump inhibitor (PPI) used for the short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD), maintenance of healing of erosive esophagitis, and pathological hypersecretory conditions, including Zollinger-Ellison syndrome. The recommended dosage is 40 mg once daily for up to 8 weeks in adults and children 5 years and older. Important safety information includes contraindications for patients with known hypersensitivity to any component of the formulation, warnings for acute interstitial nephritis, Clostridium difficile-associated diarrhea, and bone fracture, as well as potential interactions with other drugs. Special population considerations include use during pregnancy, nursing mothers, pediatric use, and geriatric use.
Contraindicated in patients with known hypersensitivity to any component of the formulation
No dosage adjustment is recommended based on age, but dose adjustments may be necessary for patients with severe renal impairment or hepatic impairment
40 mg once daily for up to 8 weeks
20 mg once daily for up to 8 weeks for children 5-14 years old, 40 mg once daily for up to 8 weeks for children 15-17 years old
40 mg once daily
Not established